Rapid antifungal susceptibility testing of fluconazole and amphotericin B by flow cytometry using FUN-1®: a preliminary study

Journal de Mycologie Medicale

Volumn 16, Issue 3, 2006, Pages 126-133

  Parisi Duchene E ^a   Reibel, C ^a   Grawey, I ^a   Heller, R ^a   Mazurier, I ^a   de Briel, D A ^a   Moskovtchenko, P ^a  

^a Pasteur Hospital   (France)

Author keywords

Antifungal susceptibility; Candida spp.; Flow cytometry; FUN 1

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUOROCHROME;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANDIDA; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SCREENING; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; FUNGAL STRAIN; INCUBATION TIME; INTERMETHOD COMPARISON; MYCOSIS; NONHUMAN; REFERENCE VALUE; REPRODUCIBILITY; STAINING;

CANDIDA; CANDIDA ALBICANS;

EID: 33749188116     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2006.07.003     Document Type: Article

References (24)

1. Alvarez-Barrientos A., Arroyo J., Canton R., Nombela C., and Sanchez-Perez M. Applications of flow cytometry to clinical microbiology. Clin. Microbiol. Rev. 13 (2000) 167-195
2. Chaturvedi V., Ramani R., and Pfaller M.A. Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing on Candida albicans. J. Clin. Microbiol. 42 (2004) 2249-2251
3. Espinel-Ingroff A., Barchiesi F., Hazen K.C., Martinez-Suarez J.V., and Scalise G. Standardization of antifungal susceptibility testing and clinical relevance. Med. Mycol. 36 (1998) 68-78
4. Espinel-Ingroff A., Warnock D.W., Vazquez J.A., and Arthington-Skaggs B.A. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med. Mycol. 38 (2000) 293-304
5. Favel A., Peyron F., De Meo M., Michel-Nguyen A., Carriere J., Chastin C., et al. Amphotericin B susceptibility testing of Candida lusitaniae isolates by flow cytofluorometry : comparison with the Etest and the NCCLS broth macrodilution method. J. Antimicrob. Chemother. 43 (1999) 227-232
6. Gökahmetoǧlu S., Nedret Koç A., and Patiroǧlu T. Antifungal susceptibility testing of Candida albicans by flow cytometry. Mycoses 46 (2003) 289-293
7. Green L., Petersen B., Steimel L., Haeber P., and Current W. Rapid determination of antifungal activity by flow cytometry. J. Clin. Microbiol. 32 (1994) 1088-1091
8. Lee W., and Kwak Y. Antifungal susceptibility testing of Candida species by flow cytometry. J. Korean Med. Sci. 14 (1999) 21-26
9. Lewis R.E., Klepser M.E., and Pfaller M.A. Update on clinical antifungal susceptibility testing for Candida species. Pharmacotherapy 18 (1998) 509-515
10. Millard P.J., Roth B.L., Truong-Thi H.P., Yue S.T., and Haugland R.P. Development of the FUN-1 family of fluorescent Probes for vacuole labeling and viability testing of yeasts. Appl. Environ. Microbiol. 63 (1997) 2897-2905
11. http://www.probes.invitrogen.com.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Second edition. Document M27-A2 2002; vol 22, 15.
13. Peter J., Armstrong D., Lyman C.A., and Walsh T.J. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. J. Clin. Microbiol. 43 (2005) 3788-3792
14. Pina-Vaz C., Sansonetty F., Rodrigues A.G., Costa-Oliveira S., Martinez-De-Oliveira J., and Fonseca A.F. Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy. J. Med. Microbiol. 50 (2001) 375-382 (a)
15. Pina-Vaz C., Sansonetty F., Rodrigues A.G., Costa-Oliveira S., Tavares C., and Martinez-De-Oliveira J. Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals. Clin. Microbiol. Infect. 7 (2001) 609-618 (b)
16. Pina-Vaz C., Costa-Oliveira S., Rodrigues A.G., and Espinel-Ingroff A. Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry. J. Clin. Microbiol. 43 (2005) 4674-4679
17. Ramani R., and Chaturvedi V. Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test. Antimicrob. Agents Chemother. 44 (2000) 2752-2758
18. Ramani R., Ramani A., and Wong S.J. Rapid flow cytometry susceptibility testing of Candida albicans. J. Clin. Microbiol. 35 (1997) 2320-2324
19. Rex J.H., Pfaller M.A., Walsh T.J., Chaturvedi V., Espinel-Ingroff A., Ghannoum M.A., et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14 (2001) 643-658
20. Shapiro H.M. New applications of flow cytometry: microbiology. Clin. Lab. Med. 21 (2001) 897-909
21. Sincock S.A., and Robinson J.P. Flow cytometric analysis of micro-organisms. Methods Cell Biol. 64 (2001) 511-537
22. Vale-Silva L.A., and Buchta V. Antifungal susceptibility testing by flow cytometry: is it the future?. Mycoses 49 (2006) 261-273
23. Wenisch C., Linnau K.F., Parschalk B., Zedtwitz-Liebenstein K., and Georgopolous A. Rapid susceptibility testing of fungi by flow cytometry using vital staining. J. Clin. Microbiol. 35 (1997) 5-10
24. Wenisch C., Moore C.B., Krauser R., Presterl E., Pichna P., and Denning D.W. Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome. J. Clin. Microbiol. 39 (2001) 2458-2462